SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-060211
Filing Date
2024-05-13
Accepted
2024-05-13 07:26:22
Documents
6
Effectiveness Date
2024-05-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2414093d1_s8.htm S-8 33087
2 EXHIBIT 5.1 tm2414093d1_ex5-1.htm EX-5.1 9010
3 EXHIBIT 23.1 tm2414093d1_ex23-1.htm EX-23.1 2308
4 EX-FILING FEES tm2414093d1_ex-filingfees.htm EX-FILING FEES 12342
5 GRAPHIC tm2414093d1_ex5-1img01.jpg GRAPHIC 9359
6 GRAPHIC tm2414093d1_ex5-1img02.jpg GRAPHIC 11225
  Complete submission text file 0001104659-24-060211.txt   86598
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 934958665 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279354 | Film No.: 24936873
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)